Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06372288 · ClinicalTrials.gov registry record · NA

Theta Burst TMS for Treatment of Methamphetamine Use Disorder

A NA study of Methamphetamine Abuse, sponsored by Carilion Clinic.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06372288 is a NA study of Methamphetamine Abuse that is actively recruiting participants, run by Carilion Clinic. The registered enrollment target is 40 participants, below the 206-participant average among 15 other Methamphetamine Abuse trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06372288, a NA study of Methamphetamine Abuse, is actively recruiting participants, sponsored by Carilion Clinic.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study is using Transcranial Magnetic Stimulation (TMS) to determine if interventional psychiatry treatment can help with the treatment of Methamphetamine Use Disorder. Individuals with Methamphetamine Use Disorder will receive 5 consecutive TMS treatment sessions based off of randomization. Participants will be randomized to one of two groups. TMS treatment arm or sham-TMS arm.

Conditions Studied

Interventions

  • DEVICE Transcranial Magnetic Stimulation
  • DEVICE Sham Transcranial Magnetic Stimulation

Study Locations (1)

Virginia

  • Carilion Clinic - Roanoke

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-12-20
Est. Completion 2025-12
Phase NA

Sponsor

Carilion Clinic

45 total trials

What the Registry Record Tells You About NCT06372288

The ClinicalTrials.gov registry entry for NCT06372288 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 206-participant average among 15 other Methamphetamine Abuse trials with a reported enrollment target (81% lower). The listed sponsor is Carilion Clinic, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Methamphetamine Abuse appearing as the primary indexed condition, and to 2 interventions - of which Transcranial Magnetic Stimulation is the first listed.

NCT06372288 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT06372288 about?

NCT06372288 is a clinical study titled "Theta Burst TMS for Treatment of Methamphetamine Use Disorder". This study is using Transcranial Magnetic Stimulation (TMS) to determine if interventional psychiatry treatment can help with the treatment of Methamphetamine Use Disorder. Individuals with Methamphetamine Use Disorder will receive 5 consecutive TMS treatment sessions based off of randomization. Par...

What is the current status of trial NCT06372288?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-12-20. Estimated completion is 2025-12.

What conditions does trial NCT06372288 study?

This clinical trial studies the following conditions: Methamphetamine Abuse.

What interventions are being tested in trial NCT06372288?

The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE), Sham Transcranial Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT06372288?

This trial is sponsored by Carilion Clinic, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06372288 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Methamphetamine Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.